Imatinib vs Levodopa
Imatinib vs Levodopa: Overview
This comparison examines the pharmacological differences between Imatinib and Levodopa.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Levodopa: Metabolic precursor of dopamine that crosses the BBB.
Pharmacokinetics
Half-life: Imatinib — 18 hours; Levodopa — 1.5 hours.
Chemical Properties
Molecular Formula: Imatinib — C29H31N7O; Levodopa — C9H11NO4.
Molecular Weight: Imatinib — 493.6030 g/mol; Levodopa — 197.1880 g/mol.
Type: Imatinib — Small molecule; Levodopa — Small molecule.